✦ LIBER ✦

6551 POSTER Efficacy and safety of single-agent axitinib (AG-013736; AG) in patients (pts) with advanced non-small cell lung cancer (NSCLC): a phase II trial

✍ Scribed by von Pawel, J.; Larson, T.; Ou, S.I.; Limentani, S.A.; Sandler, A.B.; Vokes, E.E.; Kim, S.; Liau, K.F.; Bycott, P.W.; Schiller, J.H.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and Safety of Single-Agent Axit

✍ J.H. Schiller; J. von Pawel; T. Larson; S.I. Ou; S.A. Limentani; A.B. Sandler; E 📂 Article 📅 2007 🏛 CIG Media Group, LP. 🌐 English ⚖ 442 KB

1231 A phase I study of axitinib (AG-013

✍ M.F. Kozloff; L.P. Martin; M. Krzakowski; T.A. Samuel; J. Tarazi; B. Rosbrook; M 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 52 KB

P-522 A phase II trial of Alimta plus ca

✍ Zinner, Ralph G.; Obasaju, Coleman K.; Fossella, Frank V.; Pisters, Katherine M. 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 152 KB

Phase II trial of MTA (AlimtaTM) and cis

✍ Shepherd, F.A; Arnold, A; Neville, A; Dancey, J; Rusthoven, J; Fisher, B; Eisenh 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 113 KB

A Phase I Trial of Sunitinib and Rapamyc

✍ Waqar, Saiama N.; Gopalan, Priya K.; Williams, Kristina; Devarakonda, Siddhartha 📂 Article 📅 2013 🏛 S. Karger AG 🌐 English ⚖ 428 KB

Cisplatin and gemcitabine combined with

✍ R. Zinner; B. Glisson; K. Pisters; F. Khuri; Y. Oh; J. Ro; N. Ordonez; A. El-Nag 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 140 KB